T. Rowe Price Associates
ITCI

T. Rowe Price Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-115,424
Closed -$15.2M 3181
2025
Q1
$15.2M Sell
115,424
-474,482
-80% -$62.6M ﹤0.01% 1018
2024
Q4
$49.3M Sell
589,906
-452,549
-43% -$37.8M 0.01% 761
2024
Q3
$76.3M Sell
1,042,455
-385,955
-27% -$28.2M 0.01% 629
2024
Q2
$97.8M Buy
1,428,410
+224,442
+19% +$15.4M 0.01% 547
2024
Q1
$83.3M Sell
1,203,968
-56,929
-5% -$3.94M 0.01% 590
2023
Q4
$90.3M Buy
1,260,897
+604,328
+92% +$43.3M 0.01% 567
2023
Q3
$34.2M Buy
656,569
+211
+0% +$11K 0.01% 783
2023
Q2
$41.6M Buy
656,358
+112,424
+21% +$7.12M 0.01% 751
2023
Q1
$29.5M Buy
543,934
+11,797
+2% +$639K ﹤0.01% 819
2022
Q4
$28.2M Buy
532,137
+181,181
+52% +$9.59M ﹤0.01% 824
2022
Q3
$16.3M Buy
350,956
+310,214
+761% +$14.4M ﹤0.01% 965
2022
Q2
$2.33M Buy
40,742
+1,040
+3% +$59.4K ﹤0.01% 1553
2022
Q1
$2.43M Buy
39,702
+3,513
+10% +$215K ﹤0.01% 1610
2021
Q4
$1.89M Sell
36,189
-4,333
-11% -$227K ﹤0.01% 1741
2021
Q3
$1.51M Buy
40,522
+4,279
+12% +$160K ﹤0.01% 1845
2021
Q2
$1.48M Sell
36,243
-4,046
-10% -$165K ﹤0.01% 1867
2021
Q1
$1.37M Buy
40,289
+8,799
+28% +$299K ﹤0.01% 1892
2020
Q4
$1M Sell
31,490
-281,856
-90% -$8.96M ﹤0.01% 1940
2020
Q3
$8.04M Sell
313,346
-648,403
-67% -$16.6M ﹤0.01% 1344
2020
Q2
$24.7M Sell
961,749
-532,736
-36% -$13.7M ﹤0.01% 1089
2020
Q1
$23M Buy
1,494,485
+201,249
+16% +$3.09M ﹤0.01% 1022
2019
Q4
$44.4M Buy
1,293,236
+1,220,658
+1,682% +$41.9M 0.01% 958
2019
Q3
$542K Sell
72,578
-282,922
-80% -$2.11M ﹤0.01% 2058
2019
Q2
$4.61M Sell
355,500
-563
-0.2% -$7.31K ﹤0.01% 1403
2019
Q1
$4.34M Buy
356,063
+5,100
+1% +$62.1K ﹤0.01% 1416
2018
Q4
$4M Sell
350,963
-90,215
-20% -$1.03M ﹤0.01% 1428
2018
Q3
$9.57M Sell
441,178
-400,010
-48% -$8.68M ﹤0.01% 1382
2018
Q2
$14.9M Sell
841,188
-302,452
-26% -$5.34M ﹤0.01% 1278
2018
Q1
$24.1M Buy
1,143,640
+1,119,204
+4,580% +$23.6M ﹤0.01% 1118
2017
Q4
$354K Buy
24,436
+7,900
+48% +$114K ﹤0.01% 2204
2017
Q3
$261K Buy
16,536
+2,400
+17% +$37.9K ﹤0.01% 2307
2017
Q2
$176K Sell
14,136
-469,175
-97% -$5.84M ﹤0.01% 2404
2017
Q1
$7.85M Sell
483,311
-33,311
-6% -$541K ﹤0.01% 1373
2016
Q4
$7.8M Sell
516,622
-47,080
-8% -$710K ﹤0.01% 1354
2016
Q3
$8.59M Buy
563,702
+554,095
+5,768% +$8.44M ﹤0.01% 1341
2016
Q2
$373K Buy
9,607
+37
+0.4% +$1.44K ﹤0.01% 2083
2016
Q1
$266K Buy
+9,570
New +$266K ﹤0.01% 2200